Editorial: Pharmacotherapy for Obesity in Persons With Inflammatory Bowel Disease

James K Stone^{1

2}, Wael El-Matary^{2

3}

Affiliations

¹ Department of Internal Medicine, Section of Gastroenterology, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada.
² IBD Clinical and Research Center, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, Section of Pediatric Gastroenterology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Editorial

James K Stone et al. Crohns Colitis 360. 2023.

. 2023 Feb 27;5(2):otad008.

doi: 10.1093/crocol/otad008. eCollection 2023 Apr.

James K Stone^{1

2}, Wael El-Matary^{2

3}

¹ Department of Internal Medicine, Section of Gastroenterology, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada.
² IBD Clinical and Research Center, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, Section of Pediatric Gastroenterology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

No abstract available

Keywords: IBD; obesity; pharmacotherapy.

Conflict of interest statement

W.E.-M. holds the position of Associate Editor for Crohn’s & Colitis 360 and has been recused from reviewing or making decisions for the manuscript.

1. Khera R, Pandey A, Chandar AK, et al. . Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis. Gastroenterology. 2018;154(5):1309–1319.e7. - PMC - PubMed
1. Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ.. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110–121. - PMC - PubMed
1. Singh S, Heien HC, Sangaralingham L, Shah ND, Sandborn WJ.. Obesity is not associated with an increased risk of serious infections in biologic-treated patients with inflammatory bowel diseases. Clin Transl Gastroenterol. 2021;12(7):e00380. doi:10.14309/ctg.0000000000000380 - DOI - PMC - PubMed
1. Rajabnia M, Hajimirzaei SM, Hatamnejad MR, et al. . Obesity, a challenge in the management of inflammatory bowel diseases [published online ahead of print December 1, 2022]. Immunol Res. 2022;70(6):742–751. doi:10.1007/s12026-022-09315-7 - DOI - PubMed
1. Karaskova E, Velganova-veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D.. Role of adipose tissue in inflammatory bowel disease. Int J Mol Sci. 2021;22(8):4226. doi:10.3390/ijms22084226 - DOI - PMC - PubMed